In vitro inhibition of α-amylase and angiotensin converting enzyme by fava bean (Vicia faba) protein-derived peptides, as revealed by kinetics, molecular docking and molecular dynamics
- 1Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB R3T 2N2 Canada
- 2Department of Chemistry and Biochemistry, Concordia University, 7141 Sherbrooke St. West, Montreal, QC H4B 1R6 Canada
- 3Richardson Centre for Food Technology and Research, University of Manitoba, Winnipeg, MB R3T 2N2 Canada
Abstract
The present study investigated the inhibitory effects of a fava bean (Vicia faba) protein-derived peptides on α-amylase and angiotensin-converting enzyme (ACE) using an integrated approach that combined enzyme kinetics, fluorescence spectroscopy, molecular docking, and molecular dynamics (MD) simulation. Pepsin fava bean protein hydrolysate was fractionated by successive RP-HPLC, yielding bioactive fractions enriched in antioxidant and enzyme-inhibitory activities. LC–MS/MS analysis identified seven novel peptides, among which TPACSLPL showed the strongest multifunctional activity. TPACSLPL exhibited concentration-dependent antioxidant activity and significantly inhibited α-amylase (IC50 = 0.41 mg/mL) and ACE (IC50 = 0.37 mg/mL) at 1.0 mg/mL. Kinetic analysis revealed competitive inhibition for both α-amylase and ACE, characterized by an increased Km with minimal change in Vmax, indicating that the peptide primarily interferes with the substrate binding at the active site without affecting catalytic turnover. Intrinsic fluorescence spectroscopy confirmed peptide–enzyme interactions, showing fluorescence enhancement in α-amylase and marked quenching in ACE, indicative of stable complex formation. Docking studies demonstrated strong binding affinities (ΔG − 9.8 and −10.1 kcal/mol for α-amylase and ACE, respectively), while 100 ns MD simulations and molecular mechanics with generalized born surface area analysis confirmed structural stability and favourable binding energetics, particularly for ACE. These findings highlight TPACSLPL as a novel, promising multifunctional peptide candidate for managing metabolic syndrome through targeted enzyme inhibition mechanisms.
Graphical Abstract:
Related
- Angiotensin-Converting Enzyme in Patients With Early-Stage Psychosis
- Case-control study on the association of angiotensin-converting enzyme gene I/D rs4646944 single nucleotide polymorphism and young-onset cryptogenic ischemic stroke in an Algerian cohort Estudo de caso-controle sobre associação do polimorfismo de nucleotídeo único I/D rs4646944 do gene da enzima conversora de angiotensina e acidente vascular isquêmico criptogênico de início precoce em coorte argelina
- Vascular Remodelling in Idiopathic Nephrotic Syndrome with Administration of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
- Glioblastoma model mouse rescue from mortality by brain-targeted catalytically-enhanced angiotensin-converting enzyme 2 mutant-antibody fusion protein
- Obesity and Diabetes Increase SARS-CoV-2 Susceptibility Through Angiotensin-Converting Enzyme 2, Immunologic, and Gut Microbial Dysregulation
BibTeX
@article{oluwajuyitan2026vitro,
title = {{In vitro inhibition of α-amylase and angiotensin converting enzyme by fava bean (Vicia faba) protein-derived peptides, as revealed by kinetics, molecular docking and molecular dynamics}},
author = {Timilehin David Oluwajuyitan and Toluwase Hezekiah Fatoki and Stanley Chukwuejim and Deepak Kadam and Rotimi Emmaneul Aluko},
journal = {Food Production, Processing and Nutrition},
year = {2026},
month = nov,
doi = {10.1186/s43014-026-00448-y},
url = {https://doi.org/10.1186/s43014-026-00448-y},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - In vitro inhibition of α-amylase and angiotensin converting enzyme by fava bean (Vicia faba) protein-derived peptides, as revealed by kinetics, molecular docking and molecular dynamics
AU - Timilehin David Oluwajuyitan
AU - Toluwase Hezekiah Fatoki
AU - Stanley Chukwuejim
AU - Deepak Kadam
AU - Rotimi Emmaneul Aluko
PY - 2026
DA - 2026/11/10
JO - Food Production, Processing and Nutrition
DO - 10.1186/s43014-026-00448-y
UR - https://doi.org/10.1186/s43014-026-00448-y
AB - The present study investigated the inhibitory effects of a fava bean (Vicia faba) protein-derived peptides on α-amylase and angiotensin-converting enzyme (ACE) using an integrated approach that combined enzyme kinetics, fluorescence spectroscopy, molecular docking, and molecular dynamics (MD) simulation. Pepsin fava bean protein hydrolysate was fractionated by successive RP-HPLC, yielding bioactive fractions enriched in antioxidant and enzyme-inhibitory activities. LC–MS/MS analysis identified seven novel peptides, among which TPACSLPL showed the strongest multifunctional activity. TPACSLPL exhibited concentration-dependent antioxidant activity and significantly inhibited α-amylase (IC50 = 0.41 mg/mL) and ACE (IC50 = 0.37 mg/mL) at 1.0 mg/mL. Kinetic analysis revealed competitive inhibition for both α-amylase and ACE, characterized by an increased Km with minimal change in Vmax, indicating that the peptide primarily interferes with the substrate binding at the active site without affecting catalytic turnover. Intrinsic fluorescence spectroscopy confirmed peptide–enzyme interactions, showing fluorescence enhancement in α-amylase and marked quenching in ACE, indicative of stable complex formation. Docking studies demonstrated strong binding affinities (ΔG − 9.8 and −10.1 kcal/mol for α-amylase and ACE, respectively), while 100 ns MD simulations and molecular mechanics with generalized born surface area analysis confirmed structural stability and favourable binding energetics, particularly for ACE. These findings highlight TPACSLPL as a novel, promising multifunctional peptide candidate for managing metabolic syndrome through targeted enzyme inhibition mechanisms. Graphical Abstract:
SN - 2661-8974
ER -